跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 3,355 条关于
“TMPRSS2-ERG”
全部
3,355
临床试验
2,617
药物
520
机构
10
资讯
208
去年
Parabilis Medicines Demonstrates First-Ever Degradation of ERG in Prostate Cancer Models
2个月前
Pro-Neuropeptide Y Emerges as a Circulating Biomarker for Poor Prognosis in Prostate Cancer
去年
BostonGene Presents Six AI-Driven Cancer Research Studies at 2025 ASCO Annual Meeting
2年前
Discovery of Key Proteins Offers New Treatment Hope for Acute Lymphoblastic Leukemia
去年
STORM Therapeutics' NSP14 Inhibitors Show Promise Against Coronaviruses
11个月前
Parabilis Medicines Achieves First-Ever Clinical Success Targeting "Undruggable" β-Catenin:TCF Interaction with FOG-001
2个月前
Transplanted Neural Progenitor Cells Survive One Year in Retinitis Pigmentosa Patients, Phase 1/2a Trial Shows
2年前
Ophthalmology Clinical Trials Seek Novel Endpoints Beyond Visual Acuity
去年
Parabilis Medicines Appoints Fawzi Benzaghou as Chief Medical Officer to Advance "Undruggable" Cancer Targets
11个月前
Abeona Therapeutics' ABO-503 Gene Therapy Selected for FDA's Rare Disease Endpoint Advancement Pilot Program
第 1 页,共 21 页
上一页
下一页